Navigation Links
TL-2000A Auto Lensemeter

ProductsTL-2000A Auto Lensemeter
Company Tomey Corp.
Item TL-2000A Auto Lensemeter
Features Real time display and data handling. Flexibility. Accuracy and wide range. Compact and efficient.
Description The Tomey TL-2000A Auto Lensmeter is designed for fast and easy operation with advanced lens measuring features. In Auto mode, the readings are automatically held when the lens is properly aligned. Progressive lenses are automatically detected. The sophisticated alignment system guides you to correctly position the lens. The TL-2000A has been designed with a small footprint, occupying little valuable space in your refraction room or laboratory.
Info Tomey Corp.Call Tomey Corp. to buy products (US and Canada only; other locations use number below) USACanada1-866-405-0397

Customer Service: 888-449-4045
Web site: http://www.tomey.com/

Related medicine products :

1. TL-100 Auto Lensemeter
2. TL-3000B Auto Lensemeter
3. LM-770 Digital Projection Lensemeter
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products:
(Date:12/3/2008)... To Three and Half Times Greater Than Entire U.S. ...wswire/ -- If the federal government stopped the M...ollecting no more payroll taxes and allowing no mo... $52 trillion to those who have already earned the...nal Center for Policy Analysis (NCPA). , , ...
(Date:12/3/2008)...A, Mass., Dec. 3 The Belmont(R) Ra... Combat Support Hospitals to treat wounded,soldie...edited with helping to,save the life of an Omaha,...three times during a traffic stop. One of the bull...leg rupturing a major artery. , "Injury to ...
(Date:12/3/2008)...o don,t respond at first not helped by maintenance...ec. 3 (HealthDay News) -- Maintenance therapy usin...h advanced chronic hepatitis C who haven,t respond...suggests. , The study also showed a surprising ... the course of four years. , "This course of tr...
(Date:12/3/2008)... Cellastim, an animal-free recomb...n outperform animal and human derived serum in CHO...lins, CO (PRWEB) December 3, 2008 -- Cellastim has...ed albumin in CHO media and can improve both the g...across a variety of chemically defined media. , , ...
Breaking Medicine News(10 mins):Health News:Medicare, Social Security Owe Up to $52 Trillion to Current Retirees and Workers 2Health News:Belmont(R) Rapid Infuser Helps Save Officer's Life 2Health News:Hepatitis C Therapy Useless for Some 2Health News:InVitria's Cellastim Delivers Superior Results in CHO Cell Culture 2
...n and Heat cannot coexist, because heat is capable...rsity College London. With the use of DNA technolo...ior of pain receptors within cells. When the heat.... Scientists rated the benefits of heat for pain r...
...ient undergoing multiple tests to diagnose and inv...rent trend and which seemed to be promoted //by ad...f Cardiology (ESC) has recommended that an inter-d...aging techniques such as cardiovascular imaging an...
...earchers at the Monash Institute of Medical Resear...-infrared spectroscopy, which allowed scientists//...it was the first of its kind in Australia, helped ..., the fluctuating BP and brain oxygen levels of a ...
...entists at the University of Bristol have recommen... repaired by bioengineered tissue implants //witho... maturation of cartilage implanted with engineered... months and this is the first of its kind to study...
Other Medicine News:Health News:Collaborative use of Imaging Techniques proved effective in Cardiovascular Diagnosis – ESC Recommend 2Health News:Collaborative use of Imaging Techniques proved effective in Cardiovascular Diagnosis – ESC Recommend 3Health News:Preterm Babies Benefited from a New NI Spectroscopy 2Health News:Engineered Tissue Implants benefited Knee Injured patients 2
(Date:12/3/2008)... Sangamo BioSciences, Inc.,(Nasdaq: SGMO ) anno...ilestones,achieved in 2008 and preview objectives...Briefing to be held in New York City today. , D...rporation,s Research,Biotech Business Unit will d...,two companies, collaboration to commercialize zin...
(Date:12/3/2008)...m anemia and organ damage in mice and paves the wa...., Dec. 3 Using a harml...lood cells, scientists at St. Jude Children,s Rese...pathology. In their studies, the researchers found...rence from normal mice. Although the scientists ca...
(Date:12/3/2008)... The Leukemia & Lymphoma Society (LLS) and Mem...linical trial of ISF35, a cancer vaccine, at the ... , LLS is collaborating on this trial in the ...val of a novel approach aimed at treating patients...ronic lymphocytic leukemia (CLL). , , Doct...
(Date:12/3/2008)...tCall/ -- Wyeth Pharmaceuticals,a division of Wy...bmitted a,marketing authorization application (MA...proval to market its investigational 13-valent pne...nd young children. Wyeth is seeking an,indicatio...caused by the 13,serotypes included in the invest...
Breaking Medicine Technology:Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 2Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 3Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 4Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 5Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 6Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 2Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 3The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 2The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 3Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 2Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 3Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 4Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 5Sell out Crowd Honors Oral Health America 13166 1Sell out Crowd Honors Oral Health America 13166 2When the rules of the game are broken 3A Research studies sports injuries related to illegal activity 13163 1When the rules of the game are broken 3A Research studies sports injuries related to illegal activity 13163 2Stiefel Laboratories Inc Appoints New President 13162 1Stiefel Laboratories Inc Appoints New President 13162 2Technology uses live cells to detect food borne pathogens toxins 2357 1Technology uses live cells to detect food borne pathogens toxins 2357 2Technology uses live cells to detect food borne pathogens toxins 2357 3
...y 23, 2007 /PRNewswire-FirstCall/,-- Napo Pharmace...and commercialization of proprietary pharmaceutica...h local partners, announced that,Trine Pharmaceuti...ing the results of a Phase 2a study conducted in 2...able bowel syndrome,(d-IBS) today at Digestive Dis...
...ized with Genous Stent, BARCELONA, Spain, May 23, ...Genous(TM) Bio-engineered R stent compares favorab...of late thrombosis,is minimized with the Genous st...eting data presented today by Robbert de,Winter, M... Collected from more than 120 sites in 29 countrie...
Other Medicine Technology:Phase 2a Diarrhea Predominant Irritable Bowel Syndrome Results from,2006 Presented at Digestive Disease Week in Washington, D.C. 2Phase 2a Diarrhea Predominant Irritable Bowel Syndrome Results from,2006 Presented at Digestive Disease Week in Washington, D.C. 3Phase 2a Diarrhea Predominant Irritable Bowel Syndrome Results from,2006 Presented at Digestive Disease Week in Washington, D.C. 4Phase 2a Diarrhea Predominant Irritable Bowel Syndrome Results from,2006 Presented at Digestive Disease Week in Washington, D.C. 5Efficacy of OrbusNeich's Genous Bio-Engineered R Stent Compares,Favorably to Drug-Eluting Stents 2Efficacy of OrbusNeich's Genous Bio-Engineered R Stent Compares,Favorably to Drug-Eluting Stents 3